Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 529 Neoplasms 475 Carcinoma, Non-Small-Cell Lung 394 Prostatic Neoplasms 308 Colorectal Neoplasms 296 Lung Neoplasms 259 Neoplasm Metastasis 218 Ovarian Neoplasms 200 Leukemia, Myeloid, Acute 199 Pancreatic Neoplasms 187 Multiple Myeloma 175 Squamous Cell Carcinoma of Head and Neck 134 Recurrence 132 Stomach Neoplasms 131 Brain Neoplasms 126 Carcinoma, Hepatocellular 125 Melanoma 124 Endometrial Neoplasms 122 Glioblastoma 118 Triple Negative Breast Neoplasms 111 Precursor Cell Lymphoblastic Leukemia-Lymphoma 106 Hematologic Neoplasms 100 Head and Neck Neoplasms 99 Lymphoma 97 Carcinoma, Renal Cell 97 Urinary Bladder Neoplasms 93 Sarcoma 90 Glioma 88 Lymphoma, Non-Hodgkin 82 Rectal Neoplasms 81

Interventions

ribociclib 1 exemestane 1 Letrozole 1 Fulvestrant 1 Anastrozole 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Locoregional Recurrence × 90 days × Clear all

NCT05467891 2026-04-08

RaPhLRR

Hoosier Cancer Research Network

Phase 2 Recruiting

Locoregional Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡